Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Next Generation Sequencing on the European Growth Path Finds Frost & Sullivan - Next Generation Sequencers have found their way into service providing labs and the global biomedical research community
Next Generation Sequencing on the European Growth Path Finds Frost & Sullivan

 

PRZOOM - /newswire/ - London, United Kingdom, 2011/01/26 - Next Generation Sequencers have found their way into service providing labs and the global biomedical research community.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

2010 has seen a serious uptake of Next Generation Sequencing technology, and today it is perceived as an indispensable tool.

New analysis from Frost & Sullivan (pharma.frost.com) finds that the market for Next Generation Sequencing earned revenues of $746 million in 2010 and estimates this to reach $3 billion by 2017 worldwide.

“Key applications previously performed by Microarrays are now being replaced by Next Generation Sequencers, ” observes Frost & Sullivan Research Analyst, Ms. Divyaa Ravishankar. “At the same time, governments encourage the uptake of the NGS technology by facilitating a steady stream of funding.”

Both suppliers and end users have shown immense interest in driving the technology towards diagnostics applications, where it is expected to play a significant role in the next two years. However, the research realm is harnessing most benefit of Next Generation Sequencing.

The most important challenges for the technology to remain successful though, is the increase in data volume, which requires efficient data management systems as well as the interpretation and validation of new and complex findings. In order to be able to cope with the plethora of information generated through NGS, new bioinformatic software and tools are necessary. Suppliers are therefore trying to close strategic partnerships with companies offering bioinformatics solutions.

“The growing dynamism and inventiveness has resulted in the rapid uptake of Next Generation Sequencing Technology, ” says Ms. Ravishankar. “Near-term challenges will be the development of robust and extensive protocols for generating sequencing libraries, building effective new approaches for the purpose of data analysis as well as lowering the cost to sequence a human genome.” She concludes: “NGS enables a comprehensive analysis of genomes, transcriptomes, interactomes and will become an inexpensive and a widespread tool.”

Frost & Sullivan has organised an on-demand webinar, entitled European Next Generation Sequencing – From Present to Future. The webinar summarises Ms. Ravishankar’s findings by giving an introduction into the current state of the market, presenting an analysis of latest trends and developments, as well as giving a snapshot of the geographical distribution of labs in Europe as well as worldwide.

Highlights of the webinar also include an analysis of end user perspectives based on technological factors, applications based on NGS in demand, and a comparative analysis of platforms like HiSeq 2000, Ilumina GA IIx, Solid 3 Plus, Solid 4 hq, 454 GS FLX Ti. The latter takes performance factors into consideration, e.g. reagent costs incurred, expenditure in data management tools, and the ease of operation standards.

To receive a link to the recording and or further information on this research, please E: Katja Feick at katja.feick[.]frost.com with your full contact details.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

twitter.com/frost_sullivan | facebook.com/FrostandSullivan

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Next Generation Sequencing on the European Growth Path Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Katja Feick 
+49 (0) 69 7703343 katja.feick[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  Al Rowaad Advocates & Legal Consultants

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today